FDA 483 - Frank A. Sinicrope, M.D., Clinical Investigator - February 26, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Frank A. Sinicrope, M.D., Clinical Investigator in Rochester, MN, revealed significant deficiencies in the conduct of a clinical investigation. Observations included failures to adhere to the investigational plan and protocol, improper documentation of informed consent, and inadequate maintenance of case histories and physical exam data. These issues indicate a lack of control over critical aspects of clinical trial conduct and subject protection.
- Inspection Date
- February 26, 2021
- Product Type
- Drugs
ID · 8a600a4d-8419-4481-83de-fc00481e27bd